NSC |
Compound |
Enrichment |
Correlation |
NSC 710716 |
Null |
0.0282295482823988 |
-0.0020568782 |
NSC 716032 |
Null |
0.0282295482823988 |
0.14888182 |
NSC 727087 |
16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate |
0.0282295482823988 |
0.2786381 |
NSC 728038 |
2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline |
0.0282295482823988 |
0.10755729 |
NSC 736041 |
7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne |
0.0282295482823988 |
0.14239563 |
NSC 740 |
Methotrexate |
0.0282295482823988 |
0.30467259 |
NSC 335791 |
3-Azabicyclo[3.2.2]nonane-3-carbothioic acid, [1-(2-pyridinyl)butylidene]hydrazide |
0.0354402685381449 |
0.22961956 |
NSC 622700 |
Methanaminium, (2-oxo-1,3-cyclohexanediyl)bis(methyl)bis [N,N,N-trimethyl-, diiodide |
0.0354402685381449 |
0.069941186 |
NSC 630684 |
8-Quinolinecarboxaldehyde, 2-(2,4-dinitrophenyl)-2-methyl- hydrazone |
0.0354402685381449 |
0.055229697 |
NSC 675006 |
Null |
0.0354402685381449 |
0.36463162 |